Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Gordon

Showing results (111-120 of 234) with videos related to

Pageof 24
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|January 21, 2021
Prevalence of Systemic Lupus Erythematosus in the United States: Estimates From a Meta-Analysis of the Centers for Disease Control and Prevention National Lupus RegistriesPeter M Izmirly, Hilary Parton, Lu Wang, et al.
Lupus Science & Medicine|May 16, 2024
Positive psychosocial factors may protect against perceived stress in people with systemic lupus erythematosus with and without trauma historyKimberly DeQuattro, Laura Trupin, Sarah Patterson, et al.
Rheumatology Advances in Practice|March 12, 2024
Differences in management approaches for lupus nephritis within the UKSara T Ibrahim, Christopher J Edwards, Michael R Ehrenstein, et al.
Lupus|June 28, 2023
Cost-related prescription non-adherence and patient-reported outcomes in systemic lupus erythematosus: The Michigan Lupus Epidemiology & Surveillance programDeeba Minhas, Wendy Marder, Afton L Hassett, et al.
Rheumatology (Oxford, England)|June 29, 2022
Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprineJohn A Reynolds, Mary Gayed, Munther A Khamashta, et al.
Arthritis and Rheumatism|August 1, 2007
Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosusKathleen McElhone, Janice Abbott, Joanna Shelmerdine, et al.
The Journal of Rheumatology|September 3, 2010
The LupusQoL and associations with demographics and clinical measurements in patients with systemic lupus erythematosusKathleen McElhone, Madhura Castelino, Janice Abbott, et al.
Arthritis Care & Research|May 11, 2019
Dietary Omega Polyunsaturated Fatty Acid Intake and Patient-Reported Outcomes in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance ProgramPrae Charoenwoodhipong, Sioban D Harlow, Wendy Marder, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 8, 2014
Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance programEmily C Somers, Wendy Marder, Patricia Cagnoli, et al.
Arthritis Care & Research|August 3, 2020
Access and Cost-Related Nonadherence to Prescription Medications Among Lupus Patients and Controls: The Michigan Lupus Epidemiology and Surveillance ProgramDeeba Minhas, Wendy Marder, Sioban Harlow, et al.
Pageof 24

Showing results (111-120 of 234) with videos related to

Sort By:
Pageof 24
Arthritis & Rheumatology (Hoboken, N.J.)|January 21, 2021
Prevalence of Systemic Lupus Erythematosus in the United States: Estimates From a Meta-Analysis of the Centers for Disease Control and Prevention National Lupus RegistriesPeter M Izmirly, Hilary Parton, Lu Wang, et al.
Lupus Science & Medicine|May 16, 2024
Positive psychosocial factors may protect against perceived stress in people with systemic lupus erythematosus with and without trauma historyKimberly DeQuattro, Laura Trupin, Sarah Patterson, et al.
Rheumatology Advances in Practice|March 12, 2024
Differences in management approaches for lupus nephritis within the UKSara T Ibrahim, Christopher J Edwards, Michael R Ehrenstein, et al.
Lupus|June 28, 2023
Cost-related prescription non-adherence and patient-reported outcomes in systemic lupus erythematosus: The Michigan Lupus Epidemiology & Surveillance programDeeba Minhas, Wendy Marder, Afton L Hassett, et al.
Rheumatology (Oxford, England)|June 29, 2022
Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprineJohn A Reynolds, Mary Gayed, Munther A Khamashta, et al.
Arthritis and Rheumatism|August 1, 2007
Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosusKathleen McElhone, Janice Abbott, Joanna Shelmerdine, et al.
The Journal of Rheumatology|September 3, 2010
The LupusQoL and associations with demographics and clinical measurements in patients with systemic lupus erythematosusKathleen McElhone, Madhura Castelino, Janice Abbott, et al.
Arthritis Care & Research|May 11, 2019
Dietary Omega Polyunsaturated Fatty Acid Intake and Patient-Reported Outcomes in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance ProgramPrae Charoenwoodhipong, Sioban D Harlow, Wendy Marder, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 8, 2014
Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance programEmily C Somers, Wendy Marder, Patricia Cagnoli, et al.
Arthritis Care & Research|August 3, 2020
Access and Cost-Related Nonadherence to Prescription Medications Among Lupus Patients and Controls: The Michigan Lupus Epidemiology and Surveillance ProgramDeeba Minhas, Wendy Marder, Sioban Harlow, et al.
Pageof 24